Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.645 USD | -1.67% | -3.10% | -35.09% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Business Summary
Number of employees: 862
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Advanced Wound Care
93.6
%
| 422 | 93.6 % | 406 | 93.6 % | -3.96% |
Surgical and Sports Medicine
6.4
%
| 29 | 6.4 % | 28 | 6.4 % | -3.61% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 451 | 100.0 % | 433 | 100.0 % | -3.94% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gary Gillheeney
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Francisco
DFI | Director of Finance/CFO | 59 | 21-02-15 |
Patrick Bilbo
COO | Chief Operating Officer | 63 | 98-12-31 |
Lori Freedman
ADM | Chief Administrative Officer | 57 | 16-12-31 |
Mark Collins
PRN | Corporate Officer/Principal | - | 20-12-31 |
Robert Cavorsi
PRN | Corporate Officer/Principal | - | 20-12-31 |
Kurt Matheson
SAM | Sales & Marketing | - | 21-05-31 |
Corporate Officer/Principal | 59 | 02-12-31 | |
Brian Grow
PRN | Corporate Officer/Principal | 48 | 03-12-31 |
William R. Kolb
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Nussdorf
BRD | Director/Board Member | 70 | 02-12-31 |
Alan Ades
BRD | Director/Board Member | 86 | 02-12-31 |
Michael Driscoll
BRD | Director/Board Member | 63 | 22-02-14 |
Gary Gillheeney
CEO | Chief Executive Officer | 69 | 13-12-31 |
Arthur Leibowitz
BRD | Director/Board Member | 71 | 17-12-31 |
Jon Giacomin
BRD | Director/Board Member | 60 | 21-05-06 |
Robert Adès
BRD | Director/Board Member | 51 | 20-11-02 |
Michele Korfin
BRD | Director/Board Member | 53 | 22-05-02 |
Director/Board Member | 46 | 21-11-18 | |
Director/Board Member | 59 | 22-05-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 133,795,409 | 88,985,586 ( 66.51 %) | 1,222,944 ( 0.9140 %) | 66.51 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.23% | 357M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.32% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- ORGO Stock
- Company Organogenesis Holdings Inc.